Search results: Sage Journals

Open accessArticle commentaryFirst published 2018

Precise Epigenome Editing on the Stage: A Novel Approach to Modulate Gene Expression

Claudio Mussolino

Epigenetics Insights

Restricted accessReview articleFirst published November, 2017

Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System

Claudio Mussolino, Jamal Alzubi, Valentina Pennucci [...]

Human Gene Therapy

Restricted accessResearch articleFirst published September, 2019

Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration

Niloofar Farhang, Matt Ginley-Hidinger, Kristofer C. Berrett [...]

Human Gene Therapy

Restricted accessResearch articleFirst published March, 2026

Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD

Yuanbo Qin, Talha Akbulut, Rajakumar Mandraju [...]

Human Gene Therapy

Restricted accessReview articleFirst published October, 2019

Epigenetics of scleroderma: Integrating genetic,ethnic,age,and environmental effects

Paula S Ramos

Journal of Scleroderma and Related Disorders

Restricted accessResearch articleFirst published August, 2017

* CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments

Niloofar Farhang, Jonathan M. Brunger, Joshua D. Stover [...]

Tissue Engineering Part A: Research Advances

Restricted accessEditorialFirst published September, 2019

Epigenome Editing Strategies for Low Back Pain

Terence R. Flotte

Human Gene Therapy

Restricted accessResearch articleFirst published December, 2023

Landmark CRISPR Approvals and the Rise of Epigenome Editing

Geulah Livshits

GEN Biotechnology

Restricted accessResearch articleFirst published September, 2019

Multiplex Epigenome Editing of Dorsal Root Ganglion Neuron Receptors Abolishes Redundant Interleukin 6,Tumor Necrosis Factor Alpha,and Interleukin 1β Signaling by the Degenerative Intervertebral Disc

Joshua D. Stover, Niloofar Farhang, Brandon Lawrence [...]

Human Gene Therapy

Restricted accessResearch articleFirst published September, 2023

Epigenome Editing Companies Mark Preclinical Progress

Ian Clift

Genetic Engineering & Biotechnology News

Open accessArticle commentaryFirst published 2018

Precise Epigenome Editing on the Stage: A Novel Approach to Modulate Gene Expression

Claudio Mussolino

Epigenetics Insights

Restricted accessReview articleFirst published November, 2017

Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System

Claudio Mussolino, Jamal Alzubi, Valentina Pennucci [...]

Human Gene Therapy

Restricted accessResearch articleFirst published September, 2019

Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration

Niloofar Farhang, Matt Ginley-Hidinger, Kristofer C. Berrett [...]

Human Gene Therapy

Restricted accessResearch articleFirst published March, 2026

Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD

Yuanbo Qin, Talha Akbulut, Rajakumar Mandraju [...]

Human Gene Therapy

Restricted accessReview articleFirst published October, 2019

Epigenetics of scleroderma: Integrating genetic,ethnic,age,and environmental effects

Paula S Ramos

Journal of Scleroderma and Related Disorders

Restricted accessResearch articleFirst published August, 2017

* CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments

Niloofar Farhang, Jonathan M. Brunger, Joshua D. Stover [...]

Tissue Engineering Part A: Research Advances

Restricted accessEditorialFirst published September, 2019

Epigenome Editing Strategies for Low Back Pain

Terence R. Flotte

Human Gene Therapy

Restricted accessResearch articleFirst published December, 2023

Landmark CRISPR Approvals and the Rise of Epigenome Editing

Geulah Livshits

GEN Biotechnology

Restricted accessResearch articleFirst published September, 2019

Multiplex Epigenome Editing of Dorsal Root Ganglion Neuron Receptors Abolishes Redundant Interleukin 6,Tumor Necrosis Factor Alpha,and Interleukin 1β Signaling by the Degenerative Intervertebral Disc

Joshua D. Stover, Niloofar Farhang, Brandon Lawrence [...]

Human Gene Therapy

Restricted accessResearch articleFirst published September, 2023

Epigenome Editing Companies Mark Preclinical Progress

Ian Clift

Genetic Engineering & Biotechnology News